Clinical Study

Oncologic Outcomes of Surgery in T3 Prostate Cancer: Experience of a Single Tertiary Center

Table 2

Cox multivariate regression analysis of preoperative and histopathologic parameters.

ParameterOverall survivalCancer-specific survivalBiochemical progression free survival
HR95% CI valueHR95% CI valueHR95% CI value

Pathological stage0.1950.052–0.7350.0160.000.00–9.800.9230.4750.291–0.7750.003
Age1.060.977–1.1520.1621.0680.943–1.2080.291.0050.969–1.0430.779
Lymph node0.5460.158–1.880.3370.8320.166–4.2760.8230.7150.542–0.9430.018
Pre operative PSA1.0130.982–1.0460.4061.0070.964–1.0510.7661.0050.991–1.0190.490
Surgical margins0.8780.220–3.5140.8550.5220.058–4.6860.5620.7560.440–1.300.312
Biopsy Gl. score1.0720.600–1.9150.8141.0930.530–2.2510.811.0770.792–1.4660.636
Surgery Gl. score2.821.492–5.3370.0013.241.018–10.3110.042.0291.461–2.8180.0001